Mixed Phenotype Acute Leukemia has emerging NIH research funding with 3 grants totaling $918K.
1 new grant started in the last 12 months.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Mixed Phenotype Acute Leukemia. Strongest funded area: Translational / Drug Development. Largest gap: Epidemiology / Natural History.
2 funded grants in Translational / Drug Development but only 2 related publications found for mixed phenotype acute leukemia. This may indicate early-stage research that hasn't yet produced published results.
7 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for mixed phenotype acute leukemia. Existing research activity suggests this may be a viable area for grant applications.
38 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for mixed phenotype acute leukemia. Existing research activity suggests this may be a viable area for grant applications.
15 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for mixed phenotype acute leukemia. Existing research activity suggests this may be a viable area for grant applications.
Track funding opportunities for Mixed Phenotype Acute Leukemia.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.